Glycated Hemoglobin Variability Is Associated With Adverse Outcomes in Patients With Heart Failure Irrespective of Diabetic Status

Background The effect of glycated hemoglobin (HbA1c) variability on adverse outcomes in patients with heart failure (HF) is unclear. We aim to investigate the predictive value of HbA1c variability on the risks of all‐cause death and HF rehospitalization in patients with HF irrespective of their diab...

Full description

Bibliographic Details

Published in:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Main Authors:	Xin Xu, Qing‐Wen Ren, Chanchal Chandramouli, Ming‐Yen Ng, Christopher Tze‐Wei Tsang, Yi‐Kei Tse, Xin‐Li Li, Ming‐Ya Liu, Mei‐Zhen Wu, Jia‐Yi Huang, Iok‐Fai Cheang, Jie‐Fu Yang, Fang Wang, Carolyn S.P. Lam, Kai‐Hang Yiu
Format:	Article
Language:	English
Published:	Wiley 2024-05-01
Subjects:	diabetes HbA1c variability heart failure
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.123.034109